Panbela Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2014 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Panbela Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2014 to Q3 2024.
  • Panbela Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$7K, a 75% decline year-over-year.
  • Panbela Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $983K, a 1265% increase year-over-year.
  • Panbela Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $198K.
  • Panbela Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$956K, a 56% decline from 2021.
  • Panbela Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$613K, a 189% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $983K -$7K -$3K -75% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $986K $964K +$1.07M Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 -$81K -$532K -$279K -110% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $198K $558K +$126K +29.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 $72K -$4K +$831K +99.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$759K -$103K +$759K +88.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$1.52M -$253K -$562K -182% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$956K $432K +$432K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 -$1.39M -$835K -$499K -149% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$889K -$862K -$710K -467% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$179K $309K +$434K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$613K $0 -$634K -100% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $21K -$336K -$572K -242% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $593K -$152K -$797K -124% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $1.39M -$125K +$699K +84.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $691K $634K +$453K +250% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-24
Q3 2020 $238K $236K +$458K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$220K $645K +$1.9M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$2.12M -$824K +$175K +17.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$2.29M $181K +$375K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$2.67M -$222K -$159K -252% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$2.51M -$1.25M +$215K +14.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 -$2.72M -$999K -$456K -84% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 -$2.27M -$194K +$234K +54.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-24
Q3 2018 -$2.5M -$63K +$308K +83% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$2.81M -$1.47M -$1.1M -303% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-13
Q1 2018 -$1.71M -$543K +$3.19M +85.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$4.89M -$428K -$215K -101% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-22
Q3 2017 -$4.68M -$371K -$382K -3473% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$4.3M -$364K -$245K -206% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$4.05M -$3.73M -$3.77M -10464% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$285K -$213K -$145K -213% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-21
Q3 2016 -$140K $11K +$57K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$197K -$119K -$59K -98.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-10
Q1 2016 -$138K $36K +$101K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$239K -$68K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 -$46K -$12K -35.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$60K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$65K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
Q3 2014 -$34K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.